Cargando…
Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
[Figure: see text]
Autores principales: | Varona, Jose F, Núñez, Elena, Fernández Félix, Borja M., Castellano Vázquez, Jose María, Cubillo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007736/ https://www.ncbi.nlm.nih.gov/pubmed/35094895 http://dx.doi.org/10.1016/j.ejim.2022.01.031 |
Ejemplares similares
-
EVALUATION OF THERAPEUTIC VS PROPHYLACTIC ANTICOAGULATION IN NONCRITICALLY ILL PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: GHOSH, KULDEEP, et al.
Publicado: (2022) -
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
por: Poletto, Francesco, et al.
Publicado: (2022) -
Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin
por: Cruz, Milagros, et al.
Publicado: (2011) -
Bemiparin sodium: Thrombocytopenia: case report
Publicado: (2022) -
Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
por: Kovačević, Tijana, et al.
Publicado: (2016)